UK bans single-use vapes to stem use by children and reduce harmful litter
HighlightsA ban on disposable vapes has been implemented across the United Kingdom to curb usage among children, reduce litter, and prevent environmental harm from harmful chemicals. The ban prohibits the sale of both nicotine and non-nicotine disposable vapes, while allowing retailers to continue selling reusable vapes. The United Kingdom Vaping Industry Association expressed concerns that the ban may lead former smokers back to combustible tobacco or unregulated vaping products.
A ban on disposable vapes came into force across the U.K. on Sunday as the British government aims to stem their use by children, reduce litter and prevent the leaking of harmful chemicals into the environment.
The ban makes it illegal for any retailer - online or in-store - to sell vapes, whether they contain nicotine or not. They will still be able to sell reusable vapes.
The crackdown follows the soaring use of disposable vapes in schools and a rising tide of trash as users dispose of the vapes. It is estimated that as many as 5 million disposable vapes are thrown in bins or littered every week across the U.K., rather than being recycled.
A number of countries are seeking to regulate the vape market, which has grown exponentially over the past decade or so. Australia outlawed the sale of vapes outside pharmacies last year in some of the world's toughest restrictions on electronic cigarettes, while Belgium became the first European Country to ban the use of disposable vapes at the start of this year. California has been at the forefront of bringing in new regulations in the U.S.
The U.K.'s Department for Environment, Food and Rural Affairs said usage among young people remained too high, and the ban would "put an end to their alarming rise in school playgrounds and the avalanche of rubbish flooding the nation's streets."
Also known as single-use vapes, disposable vapes are non-refillable and unable to be recharged, and are typically thrown away with general waste or just thrown on the street. Even when they are recycled, they need to be taken apart by hand, while their batteries are a fire risk to recycling facilities and can leak harmful chemicals into the environment and potentially harming wildlife.
Businesses were given six months to prepare for the change by selling any existing stock. Rogue traders who continue to sell them risk a fine of 200 ($260) in the first instance, followed by an unlimited fine or jail time for repeat offending.
The U.K. Vaping Industry Association said its members had moved quickly to comply with the June 1 deadline, but warned of "serious unintended consequences" emanating from too much regulation.
"We are concerned that this ban will encourage former smokers who have already transitioned from cigarettes, which kill 220 people every day in the U.K, to return to combustible tobacco or opt for unregulated vapes," said its director general, John Dunne.
Separately, the British government is legislating to potentially restrict the packaging, marketing and flavors of e-cigarettes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
a day ago
- The Hindu
Europe suffers its largest diphtheria outbreak in 70 years
The largest diphtheria outbreak to strike Western Europe in 70 years has been affecting vulnerable people such as migrants and the homeless since 2022, new research said Wednesday. Diphtheria is a highly contagious bacterial infection that can attack the respiratory tract and spread throughout the body, causing a sore throat, fever and other symptoms. For unvaccinated people, it can be fatal in around 30 percent of cases, and is deadlier for children, according to the World Health Organization. In 2022, there was an unusual surge in the bacteria that causes diphtheria -- Corynebacterium diphtheriae -- in several European countries, particularly among recently arrived migrants, according to a study in the New England Journal of Medicine. That year 362 cases were recorded by the European Centre for Disease Prevention and Control. Contact tracing and screening helped tamp down the outbreak, but rare infections have continued to be recorded, the researchers said. A total of 536 cases, including three deaths, have been recorded across Europe since the start of 2022. Patient samples from 10 countries showed that 98 percent of the cases were in males with an average age of 18. Almost all had recently migrated. "The outbreak, which mainly affected migrants from Afghanistan and Syria, was not the result of people being infected in their countries of origin, but during their migration journeys or in their places of accommodation in European countries," said a joint statement from France's public health agency and the Pasteur Institute. The genetic similarities between the strains seen in people from different countries suggests that there was a "recent point of contact, outside the country of origin" at the source of the outbreak, the statement added. The exact areas affected by the outbreak remains unclear. But a genetic link between the 2022 strain and the one detected in Germany this year indicates that "the bacteria continues to circulate quietly in Western Europe," the statement said. Vaccination is very effective at fending off diphtheria, and the researchers emphasised the importance of immunisation programmes for the general public. They also called for European nations to do more to ensure their most vulnerable people avoid contracting the disease. That included raising awareness of the symptoms among doctors and those in contact with migrants and the homeless, as well as increasing access to vaccines and antibiotic drugs.
Time of India
a day ago
- Time of India
Secret leprosy infected the Americas before European arrival
Representative image (AP) What to know: Leprosy is one of the oldest human diseases and originated in Eurasia or Africa A new study has found a different species of leprosy-causing bacteria existed in the Americas before European settlement. Scientists once believed Europeans brought leprosy to the American continents via infection from the bacterial species Mycobacterium leprae. But now a new study published in the journal Science reveals that a different form of leprosy-causing bacteria — called Mycobacterium lepromatosis — was already circulating in the Americas for at least one thousand years. Leprosy was therefore already affecting American indigenous peoples well before European colonization. Mycobacterium lepromatosis in America The study authors analyzed more than 800 samples taken from ancient remains in Canada and Argentina. The genomes of the bacteria taken from the samples were reconstructed, analyzed, and dated. Comparisons between the samples showed the bacterial genomes were of distinctive branches of the lepromatosis species at each end of the continent. However, they remained genetically similar. This suggested that the bacteria species had spread rapidly across the Americas, probably covering the landmass in just a few hundred years. Leprosy is caused by two bacteria species, not one. Leprosy is an ancient disease Leprosy has been infecting humans for thousands of years. The disease presents as multiple numbing skin lesions. If left untreated, it can result in nerve damage, muscle weakness, paralysis and blindness. Today, leprosy can be treated with antibiotics, but ancient sufferers weren't so fortunate. Skeletal records from 2,000BCE have been found in India with traces of the disease caused by Mycobacterium leprae. These are matched by written records of leprosy cases in ancient literature from Indian, Chinese and African civilizations, as well as stories in the Abrahamic religions. Often, these ancient descriptions associated the affliction with stigmas of immorality or ritual uncleanliness. But in 1874 the Norwegian doctor Gerhard Armauer Hansen discovered that leprosy was caused by the microscopic organism Mycobacterium leprae. In 2008, doctors in Mexico found another leprosy-causing bacteria species — Mycobacterium lepromatosis — in a leprosy patient. Before this, it was believed leprae was the only pathogen capable of causing the disease. Now both forms of the bacteria are known to cause it. Europeans spread diseases, leprosy too Nicolas Rascovan, head of the Microbial Paleogenomics Unit at the Pasteur Institut in France led the investigation. He and his colleagues estimate lepromatosis and leprae diverged from a common ancestor about one million years ago. "The diversification happened probably independent of humans," Rascovan told DW. The arrival of the first European fleets to the Americas in 1492 marked the introduction of new diseases to the Americas. Leprosy — in the form of the leprae bacterium — was among them. Archaeological evidence has shown leprae migrated with human groups out of Africa and into Asia and Europe around 40,000 years ago. Its introduction to the Americas, along with other diseases, by Europeans devastated indigenous communities and intensified the impact of pathogens that were already circulating before colonization. The discovery of lepromatosis' longer history on the continent further highlights the diversity of pathogens and their complex relationship with humans throughout history, said Rascovan. "Europeans had a very important impact by bringing this new species [leprae] that was absent in America," he said. Leprosy track and trace Rascovan hopes the presence of lepromatosis in the archeological record will improve understanding of pre-colonial disease, especially in the absence of written records. In addition, the study helps understand modern cases of leprosy, especially how it could make the jump from animals like squirrels to humans. "Our work is giving the kick start to really start analyzing, monitoring and understanding the diversity of natural reservoirs [disease carriers]," said Rascovan. He said monitoring the disease and preventing spillovers from animals to humans should be a priority. The disease is still prevalent today — 200,000 cases are reported each year globally. Brazil, India and Indonesia still report more than 10,000 new cases annually, according to WHO data.
News18
a day ago
- News18
Onion Extract May Boost Diabetes Drug Effect 4X, Says New Study
Last Updated: Recent research shows onion extract can reduce blood sugar levels by up to 50%. Scientists say it may be an effective, natural way to help control diabetes The number of diabetes patients is rising rapidly across the globe, and India is no exception. Over 10 crore people in the country are currently living with diabetes, while around 15 crore more are at high risk. This lifestyle disease, once diagnosed, requires lifelong management of blood sugar levels. Most patients rely on daily medication or insulin, which can be costly. However, scientists have now found a simpler and more affordable way to help manage blood sugar and that is onion extract. According to a report by British website Express, recent research has revealed that onion extract may significantly reduce blood sugar levels. Scientists claim that consuming onion extract can lower blood sugar by up to 50%. When taken alongside prescribed diabetes medicines, it can offer four times greater benefit. Moreover, it may also help in reducing cholesterol levels. The combination of onion extract and the common diabetes drug metformin showed promising results, and importantly, no side effects were reported. In the study, researchers gave diabetic rats onion extract in doses of 200, 400, and 600 mg per kilogram of body weight. The 400 mg/kg dose reduced their blood sugar by 50%, while the 600 mg/kg dose showed a 35% drop. Cholesterol levels also dropped significantly. While this study was conducted on animals, scientists are hopeful that similar results could be achieved in humans. They believe onion extract could be one of the most accessible and affordable supplements for diabetes care. However, experts advise caution. This potential remedy should only be tried under the supervision of a medical professional. Excessive consumption of onions can lead to other health issues. Diabetic patients must continue to monitor their blood sugar levels regularly and follow a balanced diet. Any new treatment should be taken only after consulting a doctor. First Published: June 05, 2025, 13:14 IST
